Exec advised hip recall months before J&J acted; Shire pays $48M to settle Adderall XR case;

@FiercePharma: Daiichi sales reps sue for discrimination. $100M damages sought. Same law firm that handled Novartis case. Story | Follow @FiercePharma

@EricPFierce: Merck to whittle away further at its manufacturing network. More | Follow @EricPFierce

@AlisonBFierce: Feds nail supplier of unapproved cancer drugs. This after authorities found counterfeit Altuzan making the rounds. News | Follow @AlisonBFierce

> A top marketing executive at Johnson & Johnson's ($JNJ) DePuy unit flagged safety problems in the ASR hip replacement device and suggested a recall almost a year before the company pulled the product, according to testimony in a product liability suit. Report

> Shire ($SHPG) paid Impax Laboratories ($IPXL) $48 million to settle a legal battle over Shire's agreement to supply an authorized generic version of the ADHD drug Adderall XR. Report

> Once again, drugmakers stand among the list of companies forced to pay up as the U.S. government prosecutes Medicare and Medicaid fraud. Report

> U.S.-based Perrigo ($PRGO) expanded its presence in the U.K. with a £180 million ($281.8 million) buyout of Rosemont, a privately held company that makes liquid versions of drugs. Report

Medical Device News

 @FierceMedDev: Biodegradable plastics + stem cells rebuild broken bone. Item | Follow @FierceMedDev

 @MarkHFierce: U.K. researchers developed a stem/cell device hybrid device that repairs broken bones and then biodegrades. Release | Follow @MarkHFierce

 @DamianFierce: Endo's likely headed for a sale, and some analysts say device giant Covidien would be a perfect match. Report | Follow @DamianFierce

> Swiss stent developer grabs $4.3M series B in crowded EU market. Story

> Stimatix looks for partner, buyer as it eyes stoma market. News

> Nanomix rolls out U.S. trial for heart attack blood Dx. Article

Biotech News

 @FierceBiotech: New special report: 25 most influential people in biopharma today. Report | Last year's list: More | Follow @FierceBiotech

@JohnCFierce: StemCells is jumping on very early, positive results from tiny spinal cord study. Release | Follow @JohnCFierce

@RyanMFierce: Burrill backed India-based outfit with diagnostics biz ambitions. Burrill & Co. landed $505M for latest VC fund. News | Follow @RyanMFierce

> Analysts urge AstraZeneca's Soriot to think big on M&A front. Story

> Merck ups autoimmune prize to $600M for small Michigan biotech. More

> StemCells soars after spinal trial gains persist in 2 patients. Item

Biotech Research News

> Stem cell discovery could drive new bone repair therapies. Article

> Acorda drug boosts motor functions in rats after stroke. Report

> Compound preserves heart cells, tissue after heart attack or stroke damage. Story

> Dogs with diabetes 'cured' with gene therapy. Item

Pharma Manufacturing News

> Kazakhstan government plans to build biologics plant. Article

> Japan's Eisai sells Taiwan plant in revamp of manufacturing. Story

> Feds nail supplier of unapproved cancer drugs. News

> More Merck manufacturing cuts on the way. Report

And Finally... Researchers found scads of antibiotic-resistance genes in manure-fertilized soil near Chinese pig farms. Report